Walker-Sperling, Victoria E. K.
Mercado, Noe B. http://orcid.org/0000-0001-7769-7326
Chandrashekar, Abishek http://orcid.org/0000-0001-7821-5552
Borducchi, Erica N.
Liu, Jinyan
Nkolola, Joseph P.
Lewis, Mark http://orcid.org/0000-0001-7852-0135
Murry, Jeffrey P.
Yang, Yunling
Geleziunas, Romas
Robb, Merlin L. http://orcid.org/0000-0003-3949-9649
Michael, Nelson L. http://orcid.org/0000-0001-5882-5548
Pau, Maria G.
Wegmann, Frank http://orcid.org/0000-0002-9821-1492
Schuitemaker, Hanneke http://orcid.org/0000-0001-8563-2266
Fray, Emily J.
Kumar, Mithra R.
Siliciano, Janet D.
Siliciano, Robert F.
Barouch, Dan H. http://orcid.org/0000-0001-5127-4659
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI124377, AI126603, AI128751, AI129797, AI164556)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD024917)
Janssen Research and Development
Gilead Sciences
Ragon Institute of MGH, MIT and Harvard
Article History
Received: 6 December 2021
Accepted: 8 June 2022
First Online: 16 June 2022
Competing interests
: Jeff Murray, Yunling Yang, and Romas Geleziunas are employees of Gilead Sciences. Maria G. Pau, Frank Wegmann, and Hanneke Schuitemaker are employees of Janssen Vaccines & Prevention. The other authors declare no competing interests.